跳转至内容
Merck
CN

主要文件

查看所有文档

A3007

N-乙酰胞壁酸

≥98% (TLC)

别名:

( R )-2-（乙酰氨基）-3- O -（1-羧乙基）-2-脱氧- D -葡萄糖, 2-乙酰胺基-2-脱氧-3- O -（ D -1-羧乙基）- D -吡喃葡萄糖, MurNAc, NAMA

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:
C11H19NO8
化学文摘社编号:
10597-89-4
分子量:
293.27
UNSPSC Code:
12352201
NACRES:
NA.25
PubChem Substance ID:
24890714
MDL number:
MFCD00221511
Beilstein/REAXYS Number:
1994245
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

synthetic

Quality Level

200

assay

≥98% (TLC)

form

powder

technique(s)

thin layer chromatography (TLC): suitable

impurities

≤1 mol/mol methanol

color

white

mp

125  °C ((257 °F ))

solubility

water: 50 mg/mL, clear, colorless

storage temp.

2-8°C

SMILES string

CC(O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(O)=O

InChI

1S/C11H19NO8/c1-5(11(18)19)20-10(9(17)8(16)4-14)7(3-13)12-6(2)15/h3,5,7-10,14,16-17H,4H2,1-2H3,(H,12,15)(H,18,19)/t5-,7+,8-,9-,10-/m1/s1

InChI key

SOARVSUSWULNDI-TVVSKHENSA-N

相关类别

Application

N-乙酰胞壁酸 (NAMA) 是在细菌细胞壁蛋白多糖中发现的 N-乙酰葡萄糖胺的乳酸醚衍生物，作为底物用于鉴别、分化和定性 N-乙酰胞壁酸/N-乙酰葡糖胺激酶和 N-乙酰胞壁酸醚酶。

Packaging

无底玻璃瓶。内含物在插入的融合锥体内。

Other Notes

为了全面了解我们针对客户研究提供的各种单糖产品，建议您访问我们的碳水化合物分类页面。

pictograms

Health hazardExclamation mark
GHS08,GHS07

signalword

Warning

hcodes

H302,H371

Hazard Classifications

Acute Tox. 4 Oral - STOT SE 2

target_organs

Eyes,Central nervous system

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
BCCN8506
BCCL7713
BCCK5768
BCCH6400
BCCG1250

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Justin A Hutcherson et al.
Scientific reports, 7(1), 10474-10474 (2017-09-07)
The oral microflora is composed of both health-promoting as well as disease-initiating bacteria. Many of the disease-initiating bacteria are anaerobic and include organisms such as Porphyromonas gingivalis, Prevotella intermedia, Fusobacterium nucleatum, and Tannerella forsythia. Here we investigated a novel therapeutic
C S Hughes et al.
Biochimica et biophysica acta, 1861(8), 1951-1959 (2017-05-18)
A-type resistance towards "last-line" glycopeptide antibiotic vancomycin in the leading hospital acquired infectious agent, the enterococci, is the most common in the UK. Resistance is regulated by the VanR
Emma Hernandez-Sanabria et al.
Frontiers in cellular and infection microbiology, 7, 235-235 (2017-06-24)
Understanding the driving forces behind the shifts in the ecological balance of the oral microbiota will become essential for the future management and treatment of periodontitis. As the use of competitive approaches for modulating bacterial outgrowth is unexplored in the
Weidong Zhu et al.
Journal of periodontal & implant science, 46(1), 2-9 (2016-03-05)
Porphyromonas gingivalis and Tannerella forsythia have been implicated as the major etiologic agents of periodontal disease. These two bacteria are frequently isolated together from the periodontal lesion, and it has been suggested that their interaction may increase each one's virulence
Markus B Tomek et al.
Glycobiology, 27(6), 555-567 (2017-03-24)
The occurrence of nonulosonic acids in bacteria is wide-spread and linked to pathogenicity. However, the knowledge of cognate nonulosonic acid transferases is scarce. In the periodontopathogen Tannerella forsythia, several proposed virulence factors carry strain-specifically either a pseudaminic or a legionaminic
查看所有相关文献

全球贸易项目编号

货号GTIN
A3007-10MG04061833360163
A3007-100MG04061832386805
A3007-50MG04061832386812
A3007-500MG04061833360170

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持